HIV compartmentalization: A review on a clinically important phenomenon

Current HIV Research

Volumn 10, Issue 2, 2012, Pages 133-142

  Blackard, Jason T ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Compartment; Diversity; Reservoir; Variability

Indexed keywords

ANTIRETROVIRUS AGENT; RNA DIRECTED DNA POLYMERASE;

ARTICLE; BREAST MILK; CD4 LYMPHOCYTE COUNT; CD8+ T LYMPHOCYTE; CELL COMPARTMENTALIZATION; CELL DIVISION; CELL POPULATION; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; CYTOPATHOGENIC EFFECT; GENE EXPRESSION; GLYCOSYLATION; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; INTESTINE LYMPHATIC TISSUE; LANGERHANS CELL; LONGITUDINAL STUDY; NEUROPATHOLOGY; NEUROTROPISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PYROSEQUENCING; REVERSE TRANSCRIPTION; TROPISM; TUBERCULOSIS; TUMOR MICROENVIRONMENT; VIRUS GENE; VIRUS REPLICATION;

GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; PHYLOGENY; SPECIES SPECIFICITY;

EID: 84860263679     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016212799937245     Document Type: Article

References (160)

1. Korber B, Gaschen B, Yusim K, Thakallapally R, Kesmir C, Detours V. Evolutionary and immunological implications of contemporary HIV-1 variation. Br Med Bull 2001; 58: 19-42.
2. Lauring AS, Andino R. Quasispecies theory and the behavior of RNA viruses. PLoS Pathog 2010; 6: e1001005.
3. Blackard JT, Cohen DE, Mayer K. Human immunodeficiency virus superinfection and recombination: current state of knowledge and potential clinical consequences. Clinical Infectious Diseases 2002; 34: 1108-1114.
4. Littman D. Chemokine receptors: keys to AIDS pathogenesis? Cell Death Differ 1998; 93: 677-680.
5. Pearce-Pratt R, Malamud D, Phillips D. Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus. J Virol 1994; 68:2898-2905.
6. Douglas GC, Fry GN, Thirkill T, et al. Cell-mediated infection of human placental trophoblast with HIV in vitro. AIDS Research and Human Retroviruses 1991; 7: 735-7340.
7. Hatsukari I, Singh P, Hitosugi N, et al. DEC-205-mediated internalization of HIV-1 results in the establishment of silent infection in renal tubular cells. J Am Soc Nephrol 2007; 18: 780-787.
8. Lusso P, Lori F, Gallo R. CD4-independent infection by human immunodeficiency virus type 1 after phenotypic mixing with human T-cell leukemia viruses. J Virol 1990; 64: 6341-6344.
9. Harouse JM, Kunsch C, Hartle HT, et al. CD4-independent infection of human neural cells by human immunodeficiency virus type 1. J Virol 1989; 63: 2527-2533.
10. Liu Y, Liu H, Kim BO, et al. CD4-independent infection of astrocytes by human immunodeficiency virus type 1: requirement for the human mannose receptor. J Virol 2004; 78: 4120-4133.
11. Quiñones-Mateu ME, Arts E. Virus fitness: concept, quantification, and application to HIV population dynamics. Curr Top Microbiol Immunol 2006; 299: 83-140.
12. Nowak MA, Anderson RM, McLean AR, Wolfs TF, Goudsmit J, May R. Antigenic diversity thresholds and the development of AIDS. Science 1991; 254: 963-969.
13. McDonald RA, Mayers DL, Chung RC, et al. Evolution of human immunodeficiency virus type 1 env sequence variation in patients with diverse rates of disease progression and T-cell function. J Virol 1997; 71: 1871-1879.
14. Lee HY, Perelson AS, Park SC, Leitner T. Dynamic correlation between intrahost HIV-1 quasispecies evolution and disease progression. PLoS Comput Biol 2008; 4: e1000240.
15. Fan H. Influences of the long terminal repeats on retrovirus pathogenicity. Seminars in Virology 1990; 1: 165-174.
16. d'Ettorre G, Paiardini M, Ceccarelli G, Silvestri G, Vullo V. HIVassociated immune activation: from bench to bedside. AIDS Research and Human Retroviruses 2011; 27: 355-364.
17. Kondo M, Shima T, Nishizawa M, et al. Identification of attenuated variants of HIV-1 circulating recombinant form 01_AE that are associated with slow disease progression due to gross genetic alterations in the nef/long terminal repeat sequences. J Infect Dis 2005; 192: 56-61.
18. McNearney T, Hornickova Z, Templeton A, et al. Nef and LTR sequence variation from sequentially derived human immunodeficiency virus type 1 isolates. Virology 1995; 208: 388-398.
19. Blackard JT, Renjifo BR, Mwakagile D, Montano MA, Fawzi WW, Essex M. Transmission of human immunodeficiency type 1 viruses with intersubtype recombinant long terminal repeat sequences. Virology 1999; 254: 220-225.
20. Blackard JT, Renjifo B, Fawzi W, et al. HIV-1 LTR subtype and perinatal transmission. Virology 2001; 287: 261-5.
21. Blackard JT, Renjifo B, Chaplin B, Msamanga G, Fawzi W, Essex M. Diversity of the HIV-1 long terminal repeat following motherto-child transmission. Virology 2000; 274: 402-11.
22. Montano MA, Novitsky VA, Blackard JT, Cho NL, Katzenstein DA, Essex M. Divergent transcriptional regulation among expanding human immunodeficiency virus type 1 subtypes. J Virol 1997; 71: 8657-8665.
23. Quinones-Mateu ME, Mas A, de Lera TL, et al. LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression. Virus Research 1998; 57: 11-20.
24. Visco-Comandini U, Yun Z, Vahlne A, Sonnerborg A. No association of HIV type 1 long terminal repeat sequence pattern with long-term nonprogression and in vivo viral replication levels in European subjects. AIDS Research and Human Retroviruses 1999; 15: 609-617.
25. Zhang L, Huang Y, Yuan H, Chen B, Ip J, Ho D. Genotypic and phenotypic characterization of long terminal repeat sequences from long-term survivors of human immunodeficiency virus type 1 infection. J Virol 1997; 71: 5608-5613.
26. Estable M, Bell B, Merzouki A, Montaner J, O'Shaughnessy M, Sadowski I. Human immunodeficiency virus type 1 long terminal repeat variants from 42 patients representing all stages of infection display a wide range of sequence polymorphism and transcription activity. J Virol 1996; 70: 4053-4062.
27. Kirchhoff F, Greenough TC, Hamacher M, Sullivan JL, Desrosiers R. Activity of human immunodeficiency virus type 1 promoter/TAR regions and tat1 genes derived from individuals with different rates of disease progression. Virology 1997; 232.
28. Dittmar MT, Simmons G, Donaldson Y, et al. Biological characterization of human immunodeficiency virus type 1 clones derived from different organs of an AIDS patient by long-range PCR. J Virol 1997; 71: 5140-5147.
29. Donaldson YK, Bell JE, Holmes EC, Hughes ES, Brown HK, Simmonds P. In vivo distribution and cytopathology of variants of human immunodeficiency virus type 1 showing restricted sequence variability in the V3 loop. J Virol 1994; 68: 5991-6005.
30. van't Wout AB, Ran LJ, Kuiken CL, Kootstra NA, Pals ST, Schuitemaker H. Analysis of the temporal relationship between human immunodeficiency virus type 1 quasispecies in sequential blood samples and various organs obtained at autopsy. J Virol 1998; 72: 488-496.
31. Ball JK, Holmes EC, Whitwell H, Desselberger U. Genomic variation of human immunodeficiency virus type 1 (HIV-1): molecular analyses of HIV-1 in sequential blood samples and various organs obtained at autopsy. J Gen Virol 1994; 75: 867-879.
32. Hughes ES, Bell JE, Simmonds P. Investigation of the dynamics of the spread of human immunodeficiency virus to brain and other tissues by evolutionary analysis of sequences from the p17gag and env genes. J Virol 1997; 71: 1272-1280.
33. Wong JK, Ignacio CC, Torriani F, Havlir D, NJ Fitch, Richman D. In vivo compartmentalization of human immunodeficiency virus: evidence from the examination of pol sequences from autopsy tissues. J Virol 1997; 71: 2059-2071.
34. Nickle DC, Shriner D, Mittler JE, Frenkel LM, Mullins J. Importance and detection of virus reservoirs and compartments of HIV infection. Current Opinions in Microbiology 2003; 6: 410-416.
35. Song JZ, Wang B, Ge YC, Dwyer DE, Cunningham AL, Saksena N. Significance of plasma and peripheral blood mononuclear cell derived HIV-1 sequences in establishing epidemiologic linkage between two individuals multiply exposed to HIV-1. Microbial Pathogens 1999; 26: 287-298.
36. Simmonds P, Zhang LQ, McOmish F, Balfe P, Ludlam CA, Brown A. Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyteassociated proviral populations in vivo: implications for models of HIV pathogenesis. J Virol 1991; 65: 6266-6276.
37. Wang YM, Dyer WB, Workman C, Wang B, Sullivan JS, Saksena N. Molecular evidence for drug-induced compartmentalization of HIV-1 quasispecies in a patient with periodic changes to HAART. AIDS 2000; 12: 2265-2272.
38. Sarmati L, Nicastri E, Uccella I, et al. Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing. J Clin Microbiol 2003; 41: 1760-1762.
39. Turriziani O, Bucci M, Stano A, et al. Genotypic resistance of archived and circulating viral strains in the blood of treated HIVinfected individuals. J Acquir Immune Defici Syndr 2007; 44: 518-524.
40. Potter SJ, Lemey P, Achaz G, et al. HIV-1 compartmentalization in diverse leukocyte populations during antiretroviral therapy. J Leukoc Biol 2004; 76: 562-570.
41. Potter SJ, Dwyer DE, Saksena N. Differential cellular distribution of HIV-1 drug resistance in vivo: evidence for infection of CD8+ T cells during HAART. Virology 2003; 305: 339-352.
42. Fulcher JA, Hwangbo Y, Zioni R, et al. Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection. J Virol 2004; 78: 7883-7893.
43. Ince WL, Harrington PR, Schnell GL, et al. Major coexisting human immunodeficiency virus type 1 env gene subpopulations in the peripheral blood are produced by cells with similar turnover rates and show little evidence of genetic compartmentalization. J Virol 2009; 83: 4068-4080.
44. Devereux HL, Loveday C, Youle M, Sabin CA, Burke A, Johnson M. Substantial correlation between HIV type 1 drug-associated resistance mutations in plasma and peripheral blood mononuclear cells in treatment-experienced patients. AIDS Research and Human Retroviruses 2000; 16: 1025-1030.
45. Heeregrave EJ, Geels MJ, Brenchley JM, et al. Lack of in vivo compartmentalization among HIV-1 infected naïve and memory CD4+ T cell subsets. Virology 2009; 393: 24-32.
46. Schnell G, Price RW, Swanstrom R, Spudich S. Compartmentalization and clonal amplification of HIV-1 variants in the cerebrospinal fluid during primary infection. J Virol 2010; 84: 2395-407.
47. Strain MC, Letendre S, Pillai SK, et al. Genetic composition of human immunodeficiency virus type 1 in cerebrospinal fluid and blood without treatment and during failing antiretroviral therapy. J Virol 2005; 79: 1772-88.
48. Smit TK, Brew BJ, Tourtellotte W, Morgello S, Gelman BB, Saksena N. Independent evolution of human immunodeficiency virus (HIV) drug resistance mutations in diverse areas of the brain in HIV-infected patients, with and without dementia, on antiretroviral treatment. J Virol 2004; 78: 10133-48.
49. Schnell G, Spudich S, Harrington P, Price RW, Swanstrom R. Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia. PLoS Pathog 2009; 5: e1000395.
50. Ritola K, Robertson K, Fiscus SA, Hall C, Swanstrom R. Increased human immunodeficiency virus type 1 (HIV-1) env compartmentalization in the presence of HIV-1-associated dementia. J Virol 2005; 79: 10830-4.
51. Sankalé JL, De La Tour RS, Marlink RG, et al. Distinct quasispecies in the blood and the brain of an HIV-2-infected individual. Virology 1996; 226: 418-23.
52. Pillai SK, Pond SL, Liu Y, et al. Genetic attributes of cerebrospinal fluid-derived HIV-1 env. Brain 2006; 129: 1872-83.
53. Ohagen A, Devitt A, Kunstman KJ, et al. Genetic and functional analysis of full-length human immunodeficiency virus type 1 env genes derived from brain and blood of patients with AIDS. J Virol 2003; 77: 12336-12345.
54. Lamers SL, Gray RR, Salemi M, Huysentruyt LC, McGrath M. HIV-1 phylogenetic analysis shows HIV-1 transits through the meninges to brain and peripheral tissues. Infect Genet Evol 2011; 11: 31-37.
55. Korber BT, Kunstman KJ, Patterson BK, et al. Genetic differences between blood-and brain-derived viral sequences from human immunodeficiency virus type 1-infected patients: evidence of conserved elements in the V3 region of the envelope protein of brain-derived sequences. J Virol 1994; 68: 7467-7481.
56. Haggerty S, Stevenson M. Predominance of distinct viral genotypes in brain and lymph node compartments of HIV-1-infected individuals. Viral Immunology 1991; 4: 123-131.
57. Peters PJ, Bhattacharya J, Hibbitts S, et al. Biological analysis of human immunodeficiency virus type 1 R5 envelopes amplified from brain and lymph node tissues of AIDS patients with neuropathology reveals two distinct tropism phenotypes and identifies envelopes in the brain that confer an enhanced tropism and fusigenicity for macrophages. J Virol 2004; 78: 6915-6926.
58. Wei F WX, Liu L, Gao R, et al. Characterization of HIV type 1 env gene in cerebrospinal fluid and blood of infected Chinese patients. AIDS Research and Human Retroviruses 2011, Epub ahead of print.
59. Keys B, Karis J, Fadeel B, et al. V3 sequences of paired HIV-1 isolates from blood and cerebrospinal fluid cluster according to host and show variation related to the clinical stage of disease. Virology 1993; 196: 475-483.
60. Shapshak P, Segal DM, Crandall KA, et al. Independent evolution of HIV type 1 in different brain regions. AIDS Research and Human Retroviruses 1999; 15: 811-820.
61. Chang J, Jozwiak R, Wang B, et al. Unique HIV type 1 V3 region sequences derived from six different regions of brain: regionspecific evolution within host-determined quasispecies. AIDS Research and Human Retroviruses 1998; 14: 25-30.
62. Corboy JR, Garl P. HIV-1 LTR DNA sequence variation in brainderived isolates. Journal of Neurovirology 1997; 3: 331-41.
63. Ait-Khaled M, McLaughlin JE, Johnson MA, Emery V. Distinct HIV-1 long terminal repeat quasispecies present in nervous tissues compared to that in lung, blood and lymphoid tissues of an AIDS patient. AIDS 1995; 9: 675-683.
64. Cowley D, Gray LR, Wesselingh SL, Gorry PR, Churchill M. Genetic and functional heterogeneity of CNS-derived tat alleles from patients with HIV-associated dementia. J NeuroVirol 2011; 17: 70-81.
65. Power C, McArthur JC, Johnson RT, et al. Demented and nondemented patients with AIDS differ in brain-derived human immunodeficiency virus type 1 envelope sequences. J Virol 1994; 68: 4643-4649.
66. Kuiken CL, Goudsmit J, Weiller GF, et al. Differences in human immunodeficiency virus type 1 V3 sequences from patients with and without AIDS dementia complex. J Gen Virol 1995; 76: 175-180.
67. Harrington PR, Schnell G, Letendre SL, et al. Cross-sectional characterization of HIV-1 env compartmentalization in cerebrospinal fluid over the full disease course. AIDS 2009; 23: 907-915.
68. Venturi G, Catucci M, Romano L, et al. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples. J Infect Dis 2000; 181: 740-745.
69. Olivieri KC, Agopian KA, Mukerji J, Gabuzda D. Evidence for adaptive evolution at the divergence between lymphoid and brain HIV-1 nef genes. AIDS Research and Human Retroviruses 2010; 26: 495-500.
70. Churchill M, Sterjovski J, Gray L, et al. Longitudinal analysis of nef/long terminal repeat-deleted HIV-1 in blood and cerebrospinal fluid of a long-term survivor who developed HIV-associated dementia. J Infect Dis 2004; 190: 2181-2186.
71. Harrington PR, Connell MJ, Meeker RB, Johnson PR, Swanstrom R. Dynamics of simian immunodeficiency virus populations in blood and cerebrospinal fluid over the full course of infection. J Infect Dis 2007; 196: 1058-1067.
72. Smith DM, Zárate S, Shao H, Pillai SK, et al. Pleocytosis is associated with disruption of HIV compartmentalization between blood and cerebral spinal fluid viral populations. Virology 2009; 385: 204-208.
73. Brown RJ, Peters PJ, Caron C, et al. Intercompartmental recombination of HIV-1 contributes to env intrahost diversity and modulates viral tropism and sensitivity to entry inhibitors. J Virol 2011; 85: 6024-6037.
74. Abbate I, Cappiello G, Longo R, et al. Cell membrane proteins and quasispecies compartmentalization of CSF and plasma HIV-1 from aids patients with neurological disorders. Infect Genet Evol 2005; 5: 247-253.
75. Kiessling AA, Fitzgerald LM, Zhang D, et al. Human immunodeficiency virus in semen arises from a genetically distinct virus reservoir. AIDS Research and Human Retroviruses 1998; 14: S33-S41.
76. Ping LH, Cohen MS, Hoffman I, et al. Effects of genital tract inflammation on human immunodeficiency virus type 1 V3 populations in blood and semen. J Virol 2000; 74: 8946-8952.
77. Philpott S, Burger H, Tsoukas C, et al. Human immunodeficiency virus type 1 genomic RNA sequences in the female genital tract and blood: compartmentalization and intrapatient recombination. J Virol 2005; 79: 353-363.
78. Diem K, Nickle DC, Motoshige A, et al. Male genital tract compartmentalization of human immunodeficiency virus type 1 (HIV). AIDS Research and Human Retroviruses 2008; 24: 561-571.
79. Delwart EL, Mullins JI, Gupta P, et al. Human immunodeficiency virus type 1 populations in blood and semen. J Virol 1998; 72: 617-623.
80. Craigo JK, Patterson BK, Paranjpe S, et al. Persistent HIV type 1 infection in semen and blood compartments in patients after longterm potent antiretroviral therapy. AIDS Research and Human Retroviruses 2004; 20: 1196-1209.
81. Anderson JA, Ping LH, Dibben O, et al. HIV-1 populations in semen arise through multiple mechanisms. PLoS Pathog 2010; 6: e1001053.
82. Gupta P, Leroux C, Patterson BK, et al. Human immunodeficiency virus type 1 shedding pattern in semen correlates with the compartmentalization of viral quasispecies between blood and semen. J Infect Dis 2000; 182: 79-87.
83. Shen C, Ding M, Craigo JK, et al. Genetic characterization of HIV-1 from semen and blood from clade C-infected subjects from India and effect of therapy in these body compartments. Virology 2010; 401: 190-196.
84. Curran R, Ball J. Concordance between semen-derived HIV-1 proviral DNA and viral RNA hypervariable region 3 (V3) envelope sequences in cases where semen populations are distinct from those present in blood. J Med Virol 2002; 67: 9-19.
85. Boeras DI, Hraber PT, Hurlston M, et al. Role of donor genital tract HIV-1 diversity in the transmission bottleneck. Proceedings of the National Academy of Sciences USA 2011; 108: E1156-E1163.
86. Coombs RW, Speck CE, Hughes JP, et al. Association between culturable human immunodeficiency virus type 1 (HIV-1) in semen and HIV-1 RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998; 177: 320-330.
87. Paranjpe S, Craigo J, Patterson B, et al. Subcompartmentalization of HIV-1 quasispecies between seminal cells and seminal plasma indicates their origin in distinct genital tissues. AIDS Research and Human Retroviruses 2002; 18: 1271-1280.
88. Pillai SK, Good B, Pond SK, et al. Semen-specific genetic characteristics of human immunodeficiency virus type 1 env. J Virol 2005; 79: 1734-1742.
89. Liuzzi G, Chirianni A, Clementi M, et al. Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS 1996; 10: F51-F56.
90. Kalichman SC, Di Berto G, Eaton L. Human immunodeficiency virus viral load in blood plasma and semen: review and implications of empirical findings. Sexually Transmitted Diseases 2008; 35: 55-60.
91. Marcelin AG, Tubiana R, Lambert-Niclot S, et al. Detection of HIV-1 RNA in seminal plasma samples from treated patients with undetectable HIV-1 RNA in blood plasma. AIDS 2008; 22: 1677-1679.
92. Liuzzi G, Chirianni A, Zaccarelli M, et al. Differences between semen and plasma of nucleoside reverse transcriptase resistance mutations in HIV-infected patients using a rapid assay. In Vivo 2004; 18: 509-512.
93. Eron JJ, Vernazza PL, Johnston DM, et al. Resistance of HIV-1 to antiretroviral agents in blood and seminal plasma: implications for transmission. AIDS 1998; 12: F181-F189.
94. Ghosn J, Viard JP, Katlama C, et al. Evidence of genotypic resistance diversity of archived and circulating viral strains in blood and semen of pre-treated HIV-infected men. AIDS 2004; 18: 447-457.
95. Ferreira VH, Nazli A, Khan G, et al. Endometrial epithelial cell responses to coinfecting viral and bacterial pathogens in the genital tract can activate the HIV-1 LTR in an NF{kappa}B-and AP-1-dependent manner. J Infect Dis 2011; 204: 299-308.
96. Poss M, Rodrigo AG, Gosink JJ, et al. Evolution of envelope sequences from the genital tract and peripheral blood of women infected with clade A human immunodeficiency virus type 1. JVirol 1998; 72: 8240-8451.
97. Bull ME, Learn GH, McElhone S, et al. Monotypic human immunodeficiency virus type 1 genotypes across the uterine cervix and in blood suggest proliferation of cells with provirus. J Virol 2009; 83: 6020-6028.
98. Overbaugh J, Anderson R, Ndinya-Achola J, Kreiss J. Distinct but related human immunodeficiency virus type 1 variant populations in genital secretions and blood. AIDS Research and Human Retroviruses 1996; 12: 107-115.
99. Ellerbrock TV, Lennox JL, Clancy KA, et al. Cellular replication of human immunodeficiency virus type 1 occurs in vaginal secretions. J Infect Dis 2001; 184: 28-36.
100. Sullivan ST, Mandava U, Evans-Strickfaden T, Lennox JL, Ellerbrock TV, Hart C. Diversity, divergence, and evolution of cell-free human immunodeficiency virus type 1 in vaginal secretions and blood of chronically infected women: associations with immune status. J Virol 2005; 79: 9799-9809.
101. Kemal KS, Foley B, Burger H, et al. HIV-1 in genital tract and plasma of women: compartmentalization of viral sequences, coreceptor usage, and glycosylation. Proceedings of the National Academy of Science USA 2003; 100: 12972-12977.
102. Kemal KS, Burger H, Mayers D, et al. HIV-1 drug resistance in variants from the female genital tract and plasma. J Infec Dis 2007; 195: 535-545.
103. De Pasquale MP, Leigh Brown AJ, Uvin SC, et al. Differences in HIV-1 pol sequences from female genital tract and blood during antiretroviral therapy. J Acquir Immune Defic Syndr 2003; 34: 37-44.
104. Tirado G, Jove G, Kumar R, et al. Differential virus evolution in blood and genital tract of HIV-infected females: evidence for the involvement of drug and non-drug resistance-associated mutations. Virology 2004; 324: 577-586.
105. Tirado G, Jove G, Kumar R, et al. Compartmentalization of drug resistance-associated mutations in a treatment-naive HIV-infected female. AIDS Research and Human Retroviruses 2004; 20: 684-686.
106. Chaudhary S, Noel RJ, Rodríguez N, et al. Correlation between CD4 T cell counts and virus compartmentalization in genital and systemic compartments of HIV-infected females. Virology 2011; 417: 320-326.
107. Poles MA, Boscardin WJ, Elliott J, et al. Lack of decay of HIV-1 in gut-associated lymphoid tissue reservoirs in maximally suppressed individuals. J Acquir Immune Defic Syndr 2006; 43: 65-68.
108. Lerner P, Guadalupe M, Donovan R, et al. The gut mucosal viral reservoir in HIV-infected patients is not the major source of rebound plasma viremia following interruption of highly active antiretroviral therapy. J Virol 2011; 85: 4772-4782.
109. Belmonte L, Olmos M, Fanin A, et al. The intestinal mucosa as a reservoir of HIV-1 infection after successful HAART. AIDS 2007; 21: 2106-2108.
110. Zalar A, Figueroa MI, Ruibal-Ares B, et al. Macrophage HIV-1 infection in duodenal tissue of patients on long term HAART. Antiviral Research 2010; 87: 269-271.
111. van Marle G, Gill MJ, Kolodka D, McManus L, Grant T, Church D. Compartmentalization of the gut viral reservoir in HIV-1 infected patients. Retrovirology 2007; 4: 87.
112. Salemi M, Lamers SL, Huysentruyt LC, et al. Distinct patterns of HIV-1 evolution within metastatic tissues in patients with non-Hodgkins lymphoma. PLoS One 2009; 4: e8153.
113. Lamers SL, Salemi M, Galligan DC, et al. Extensive HIV-1 intrahost recombination is common in tissues with abnormal histopathology. PLoS One 2009; 4: e5065.
114. Avettand-Fenoel V, Hocqueloux L, Müller-Trutwin M, et al. Greater diversity of HIV DNA variants in the rectum compared to variants in the blood in patients without HAART. J Med Virol 2011; 83: 1499-1507.
115. Centlivre M, Sommer P, Michel M, et al. The HIV-1 clade C promoter is particularly well adapted to replication in the gut in primary infection. AIDS 2006; 20: 657-666.
116. Poles MA, Elliott J, Vingerhoets J, et al. Despite high concordance, distinct mutational and phenotypic drug resistance profiles in human immunodeficiency virus type 1 RNA are observed in gastrointestinal mucosal biopsy specimens and peripheral blood mononuclear cells compared with plasma. J Infect Dis 2001; 183: 143-148.
117. van der Hoek L, Sol CJ, Maas J, Lukashov VV, Kuiken CL, Goudsmit J. Genetic differences between human immunodeficiency virus type 1 subpopulations in faeces and serum. J Gen Virol 1998; 79: 259-267.
118. van der Hoek L, Sol CJ, Snijders F, Bartelsman JF, Boom R, Goudsmit J. Human immunodeficiency virus type 1 RNA populations in faeces with higher homology to intestinal populations than to blood populations. J Gen Virol 1996; 77: 2415-225.
119. van der Hoek L, Goudsmit J, Maas J, Sol C. Human immunodeficiency virus type 1 in faeces and serum: evidence against independently evolving subpopulations. J GenVirol 1998; 79: 2455-249.
120. Katzenstein TL, Petersen AB, Storgaard M, et al. Phylogeny and resistance profiles of HIV-1 POL sequences from rectal biopsies and blood. J Med Virol 2010; 82: 1103-1109.
121. Imamichi H, Degray G, Dewar RL, et al. Lack of compartmentalization of HIV-1 quasispecies between the gut and peripheral blood compartments. J Infect Dis 2011; 204: 309-14.
122. Chun TW, Nickle DC, Justement JS, et al. Persistence of HIV in gut-associated lymphoid tissue despite long-term antiretroviral therapy. J Infect Dis 2008; 197: 714-20.
123. Blackard JT, Ma G, Martin CM, Rouster SD, Shata MT, Sherman K. HIV variability in the liver and evidence of possible compartmentalization. AIDS Research and Human Retroviruses 2011; 27: 1117-26.
124. Collins KR, Quiñones-Mateu ME, Wu M, et al. Human immunodeficiency virus type 1 (HIV-1) quasispecies at the sites of Mycobacterium tuberculosis infection contribute to systemic HIV-1 heterogeneity. J Virol 2002; 76: 1697-1706.
125. Wang TH, Donaldson YK, Brettle RP, Bell JE, Simmonds P. Identification of shared populations of human immunodeficiency virus type 1 infecting microglia and tissue macrophages outside the central nervous system. J Virol 2001; 75: 11686-99.
126. Singh A, Besson G, Mobasher A, Collman R. Patterns of chemokine receptor fusion cofactor utilization by human immunodeficiency virus type 1 variants from the lungs and blood. J Virol 1999; 73: 6680-90.
127. Collins KR, Mayanja-Kizza H, Sullivan BA, Quinones-Mateu ME, Toossi Z, Arts E. Greater diversity of HIV-1 quaispecies in HIVinfected individuals with active tuberculosis. J Acquir Immune Defic Syndr 2000; 24: 408-17.
128. Nakata K, Weiden M, Harkin T, Ho D, WN WR. Low copy number and limited variability of proviral DNA in alveolar macrophages from HIV-1-infected patients: evidence for genetic differences in HIV-1 between lung and blood macrophage populations. Molecular Medicine 1995; 1: 744-57.
129. Toossi Z, Xia L, Wu M, Salvekar A. Transcriptional activation of HIV by Mycobacterium tuberculosis in human monocytes. Clin Exp Immunol 1999; 17: 324-30.
130. Zhang Y, Nakata K, Weiden M, Rom W. Mycobacterium tuberculosis enhances human immunodeficiency virus-1 replication by transcriptional activation at the long terminal repeat. Journal of Clinical Investigations 1995; 95: 2324-31.
131. Gantt S, Carlsson J, Heath L, et al. Genetic analyses of HIV-1 env sequences demonstrate limited compartmentalization in breast milk and suggest viral replication within the breast that increases with mastitis. J Virol 2010; 84:10812-9.
132. Gray RR, Salemi M, Lowe A, et al. Multiple independent lineages of HIV-1 persist in breast milk and plasma. AIDS 2011; 25: 143-52.
133. Becquart P, Chomont N, Roques P, et al. Compartmentalization of HIV-1 between breast milk and blood of HIV-infected mothers. Virology 2002; 300: 109-17.
134. Voulgaropoulou F, Tan B, Soares M, Hahn B, Ratner L. Distinct human immunodeficiency virus strains in the bone marrow are associated with the development of thrombocytopenia. J Virol 1999; 73: 3497-504.
135. Marras D, Bruggeman LA, Gao F, et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nature Medicine 2002; 8: 522-6.
136. Sala M, Zambruno G, Vartanian JP, Marconi A, Bertazzoni U, Wain-Hobson S. Spatial discontinuities in human immunodeficiency virus type 1 quasispecies derived from epidermal Langerhans cells of a patient with AIDS and evidence for double infection. J Virol 1994; 68: 5280-3.
137. Kumar SB, Handelman SK, Voronkin I, et al. Different regions of HIV-1 subtype C env are associated with placental localization and in utero mother-to-child transmission. J Virol 2011; 85: 7142-52.
138. Freel SA, Williams JM, Nelson JA, et al. Characterization of human immunodeficiency virus type 1 in saliva and blood plasma by V3-specific heteroduplex tracking assay and genotype analyses. J Virol 2001; 75: 4936-40.
139. Liang B, Luo M, Scott-Herridge J, et al. A comparison of parallel pyrosequencing and sanger clone-based sequencing and its impact on the characterization of the genetic diversity of HIV-1. PLoS One 2011 6: e26745.
140. Gianella S, Delport W, Pacold ME, et al. Detection of minority resistance during early HIV-1 infection: natural variation and spurious detection rather than transmission and evolution of multiple viral variants. J Virol 2011; 85: 8359-67.
141. Archer J, Braverman MS, Taillon BE, et al. Detection of lowfrequency pretherapy chemokine (CXC motif) receptor 4 (CXCR4)-using HIV-1 with ultra-deep pyrosequencing. AIDS 2009; 23: 1209-18.
142. Archer J, Rambaut A, Taillon BE, Harrigan PR, Lewis M, Robertson D. The evolutionary analysis of emerging low frequency HIV-1 CXCR4 using variants through time--an ultra-deep approach. PLoS Comput Biol 2010; 6: e1001022.
143. Rozera G, Abbate I, Bruselles A, et al. Massively parallel pyrosequencing highlights minority variants in the HIV-1 env quasispecies deriving from lymphomonocyte sub-populations. Retrovirology 2009; 6: 15.
144. Buzón MJ, Codoñer FM, Frost SD, et al. Deep molecular characterization of HIV-1 dynamics under suppressive HAART. PLoS One 2011; 7: e1002314.
145. Mantel N. The detection of disease clustering and a generalized regression approach. Cancer Research 1967; 27: 209-20.
146. Slatkin M, Maddison W. A cladistic measure of gene flow inferred from the phylogenies of alleles. Genetics 1989; 123: 603-13.
147. Critchlow DE, Li S, Nourijelyani K, Pearl D. Some statistical methods for phylogenetic tress with application to HIV disease. Math Comput Model 2000; 32: 69-81.
148. Hudson R. A new statistic for detecting genetic differentiation. Genetics 2000; 155: 2011-4.
149. Hudson RR, Boos DD, Kaplan N. A statistical test for detecting geographic subdivision. Mol Biol Evol 1992; 9: 138-51.
150. Excoffier L, Smouse PE, Quattro J. Analysis of molecular variance inferred from metric distances among DNA haplotypes: applications to human mitochondiral DNA restriction data. Genetics 1992; 131: 479-91.
151. Zárate S, Pond SL, Shapshak P, Frost S. Comparative study of methods for detecting sequence compartmentalization in human immunodeficiency virus type 1. J Virol 2007; 81: 6643-51.
152. Liu Y, Curlin ME, Diem K, et al. Env length and N-linked glycosylation following transmission of human immunodeficiency virus Type 1 subtype B viruses. Virology 2008; 374: 229-33.
153. von Briesen H, Grez M, Ruppach H, et al. Selection of HIV-1 genotypes by cultivation in different primary cells. AIDS 1999; 13: 307-15.
154. van Opijnen T, Boerlijst MC, Berkhout B. Effects of random mutations in the human immunodeficiency virus type 1 transcriptional promoter on viral fitness in different host cell environments. J Virol 2006; 80: 6678-85.
155. van Opijnen T, Berkhout B. The host environment drives HIV-1 fitness. Reviews in Medical Virology 2005; 15: 219-33.
156. Fouchier RA, Brouwer M, Kootstra NA, Huisman HG, Schuitemaker H. HIV-1 macrophage tropism is determined at multiple levels of the viral replication cycle. J Clin Invest 1994; 94: 1806-16.
157. Chun TW, Davey RT Jr, Ostrowski M, et al. Relationship between pre-existing viral reservoirs and the re-emergence of plasma viremia after discontinuation of highly active anti-retroviral therapy. Nature Medicine 2000; 6: 757-61.
158. Dybul M, Daucher M, Jensen MA, et al. Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy. J Virol 2003; 77: 3229-37.
159. Pierson T, McArthur J, Siliciano R. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy. Annu Rev Immunol 2000; 18: 665-708.
160. Kijak GH, Simon V, Balfe P, et al. Origin of human immunodeficiency virus type 1 quasispecies emerging after antiretroviral treatment interruption in patients with therapeutic failure. J Virol 2002; 76: 7000-9.